Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Benitec Biopharma Inc. (BNTC)

9.54 +0.90 (+10.42%)
At close: November 6 at 4:00:01 PM EST
9.54 0.00 (0.00%)
After hours: November 6 at 4:00:12 PM EST
Trade BNTC on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
6/30/2026
6/30/2025
6/30/2024
6/30/2023
Total Revenue
0
0
0
0
75
Cost of Revenue
--
--
--
--
0
Gross Profit
--
--
--
--
75
Operating Expense
51,192
51,192
41,765
22,490
19,156
Operating Income
-51,192
-51,192
-41,765
-22,490
-19,081
Net Non Operating Interest Income Expense
5,569
5,569
3,286
904
-33
Other Income Expense
77
77
562
-165
-448
Pretax Income
-45,546
-45,546
-37,917
-21,751
-19,562
Net Income Common Stockholders
-45,546
-45,546
-37,917
-22,370
-19,562
Diluted NI Available to Com Stockholders
-45,546
-45,546
-37,917
-22,370
-19,562
Basic EPS
-0.93
-0.98
-1.05
-1.22
-14.12
Diluted EPS
-0.93
-0.98
-1.05
-1.22
-14.12
Basic Average Shares
44,488.28
46,558.16
36,209.27
18,364.39
1,385.82
Diluted Average Shares
44,488.28
46,558.16
36,209.27
18,364.39
1,385.82
Total Operating Income as Reported
-51,192
-51,192
-41,765
-22,490
-19,081
Total Expenses
51,192
51,192
41,765
22,490
19,156
Net Income from Continuing & Discontinued Operation
-45,546
-45,546
-37,917
-21,751
-19,562
Normalized Income
-45,666
-45,666
-37,846
-21,790
-19,144
Interest Expense
--
--
--
--
33
Net Interest Income
5,569
5,569
3,286
904
-33
EBIT
-51,192
-51,192
-41,765
-22,490
-19,081
EBITDA
-50,711
-50,711
-41,369
-22,147
-18,700
Reconciled Cost of Revenue
--
--
--
--
0
Reconciled Depreciation
481
481
396
343
381
Net Income from Continuing Operation Net Minority Interest
-45,546
-45,546
-37,917
-21,751
-19,562
Total Unusual Items Excluding Goodwill
120
120
-71
39
-418
Total Unusual Items
120
120
-71
39
-418
Normalized EBITDA
-50,831
-50,831
-41,298
-22,186
-18,282
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2023 - 6/24/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: